Patents by Inventor Bidda Charlotte Rolin

Bidda Charlotte Rolin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL GLP-1 RECEPTOR AGONISTS WITH CHOLESTEROL EFFLUX ACTIVITY
    Publication number: 20150344540
    Abstract: The present invention provides novel glucagon-like protein-1 (GLP-1) receptor agonist compounds that promote cholesterol efflux. The ABCA1-mediated cholesterol efflux present invention also provides compositions comprising the novel glucagon-like protein-1(GLP-1) receptor agonist compounds, and relates to the use of said compounds in therapy, to methods of treatment comprising administration of said compounds to patients, and to the use of said compounds in the manufacture of medicaments.
    Type: Application
    Filed: December 19, 2013
    Publication date: December 3, 2015
    Inventors: Christian Wenzel Tornoee, Henning Thoegersen, Bidda Charlotte Rolin, Janos Tibor Kodra, Salka Elboel Rasmussen, Jesper Lau
  • GLP-1 AGONIST AND CARDIOVASCULAR COMPLICATIONS
    Publication number: 20140206615
    Abstract: Methods and uses for the treatment and prevention of cardiac and cardiovascular diseases comprising administration of a GLP-1 agonist.
    Type: Application
    Filed: March 28, 2014
    Publication date: July 24, 2014
    Applicant: NOVO NORDISK A/S
    Inventors: Liselotte Bjerre Knudsen, Bidda Charlotte Rolin, Richard David Carr, Johan Selmer, Jens Larsen, Bodil Elbrond, Lars Bo Nielsen, Christina Christoffersen
  • GLP-1 Agonist and Cardiovascular Complications
    Publication number: 20130338071
    Abstract: Methods and uses for the treatment and prevention of cardiac and cardiovascular diseases comprising administration of a GLP-1 agonist.
    Type: Application
    Filed: August 26, 2013
    Publication date: December 19, 2013
    Applicant: NOVO NORDISK A/S
    Inventors: Liselotte Bjerre Knudsen, Bidda Charlotte Rolin, Richard David Carr, Johan Selmer, Jens Larsen, Bodil Elbrond, Lars Bo Nielsen, Christina Christoffersen
  • GLP-I Agonist And Cardiovascular Complications
    Publication number: 20120295836
    Abstract: Methods and uses for the treatment and prevention of cardiac and cardiovascular diseases comprising administration of a GLP-1 agonist.
    Type: Application
    Filed: April 4, 2012
    Publication date: November 22, 2012
    Applicant: Novo Nordisk A/S
    Inventors: Liselotte Bjerre Knudsen, Bidda Charlotte Rolin, Richard David Carr, Johan Selmer, Jens Larsen, Bodil Elbrond, Lars Bo Nielsen, Christina Christoffersen
  • GLP-1 AND FGF21 COMBINATIONS FOR TREATMENT OF DIABETES TYPE 2
    Publication number: 20120172298
    Abstract: The invention relates to the use of a Fibroblast Growth Factor 21 (FGF21) compound and a Glucagon-Like Peptide 1 (GLP-1) compound in combination for the preparation of a medicament for the treatment of diabetes, more in particular type 2 diabetes, as well as pharmaceutical compositions comprising certain FGF21 and GLP-1 compounds in combination, together with a pharmaceutically acceptable carrier. The combination has a significant effect on parameters of relevance for diabetes type 2, viz. on the viability of beta cells ex vivo in the presence of free fatty acids, on caspase activity of beta cells ex vivo (a measure of cell apoptosis), and a blood glucose lowering effect on db/db mice in vivo.
    Type: Application
    Filed: June 8, 2010
    Publication date: July 5, 2012
    Applicant: Novo Nordisk A/S
    Inventors: Birgitte Andersen, Ann Maria Kruse Hansen, Bidda Charlotte Rolin
  • GLP-I Agonist And Cardiovascular Complications
    Publication number: 20110230409
    Abstract: Methods and uses for the treatment and prevention of cardiac and cardiovascular diseases comprising administration of a GLP-1 agonist.
    Type: Application
    Filed: June 2, 2011
    Publication date: September 22, 2011
    Applicant: Novo Nordisk A/S
    Inventors: Liselotte Bjerre Knudsen, Bidda Charlotte Rolin, Richard David Carr, Johan Selmer, Jens Larsen, Bodil Elbrond, Lars Bo Nielsen, Christina Christoffersen
  • GLP-I Agonist And Cardiovascular Complications
    Publication number: 20090215688
    Abstract: Methods and uses for the treatment and prevention of cardiac and cardiovascular diseases comprising administration of a GLP-1 agonist.
    Type: Application
    Filed: June 5, 2008
    Publication date: August 27, 2009
    Applicant: Novo Nordisk A/S
    Inventors: Liselotte Bjerre Knudsen, Bidda Charlotte Rolin, Richard David Carr, Johan Selmer, Jens Larsen, Bodil Elbrond, Lars Bo Nielsen, Christina Christoffersen
  • GLP-1 agonist and cardiovascular complications
    Publication number: 20030220255
    Abstract: Methods and uses for the treatment and prevention of cardiac and cardiovascular diseases comprising administration of a GLP-1 agonist.
    Type: Application
    Filed: April 3, 2003
    Publication date: November 27, 2003
    Inventors: Liselotte Bjerre Knudsen, Bidda Charlotte Rolin, Richard David Carr, Johan Selmer, Jens Larsen, Bodil Elbrond, Lars Bo Nielsen, Christina Christoffersen